WIT earnings call summary

Prepared Highlights

• IT Services sequential revenue at $2.64 billion, grew 1.4% on a constant currency basis (CEO); excluding HARMAN DTS acquisition, revenue grew 0.6% in constant currency (CEO)
• Operating margin at 17.6%, expanded 0.4% over adjusted Q2 margin and 0.1% year-on-year (CEO); described as “one of our best margin performance in the last several quarters” (CFO)
• Total contract value closed at $3.3 billion; large deal bookings at $871 million (CEO)
• Americas 1 delivered sequential and year-on-year growth; Americas 2 saw sequential decline; Europe grew sequentially led by ramp-up of earlier mega deal; APMEA grew sequentially and year-on-year (CEO)
• BFSI grew 2.6% sequentially and 0.4% year-on-year; Health grew 4.2% sequentially and 1% year-on-year; Consumer grew 0.7% sequentially; Tech and Com grew 4.2% sequentially and 3.5% year-on-year; EMR declined 4.9% sequentially and 5.8% year-on-year (CFO)
• Capco revenue remained flat year-on-year (CFO)
• Adjusted net income for Q3 was INR 33.6 billion; adjusted EPS at INR 3.21, up 3.5% quarter-on-quarter and flat year-on-year (CFO)
• Operating cash flow stood at 135% of net income for Q3 (CFO)
• Gross cash including investments at $6.5 billion (CFO)
• Effective tax rate at 23.9% for Q3 (CFO)
• Board declared interim dividend of INR 6 per share; cash distributed to shareholders during current financial year will exceed $1.3 billion (CFO)
• Official guidance: Q4 FY26 IT Services revenue range of $2.635 billion to $2.688 billion, translating to sequential growth of 0% to 2% in constant currency (CEO, CFO); guidance includes incremental 2 months of HARMAN DTS revenue and is impacted by fewer working days and delayed ramp-ups (CFO)

Mgmt quotes

• “AI is now a standing board level mandate led by CEOs who recognized its ability to transform business models, unlock productivity, and create lasting competitive advantage.” (CEO)
• “These milestones reflect a legacy of strong governance, value and integrity, a foundation of trust that continues to differentiate us with our clients, partners and investors.” (CEO)
• “Clients are bringing us in much earlier and recognizing the step change in the way we deliver and innovate.” (CEO)
• “This is one of our best margin performance in the last several quarters.” (CFO)
• “We've now completed the restructuring we wanted to do and do not anticipate any further charges.” (CFO)

Prepared Metrics

Q&A Batch (1-5 of 8)

Q1 — Nitin Padmanabhan

• Topic: EMR垂直行业下滑、大型交易延迟、工资上调
• Key points:
  • EMR垂直行业本季度损失约2400万美元收入，原因是宏观经济不确定性、关税及供应链中断；但管道依然强劲，集中在供应商整合和成本削减。
  • 大型交易“Phoenix”（上财年Q4赢得）已完全爬坡，收入已全部实现。
  • 其他大型交易需几个季度爬坡，Q4无法完全实现影响；Q4还面临低工作日影响，部分抵消季节性 furlough 恢复。
  • 工资上调决定将在未来几周内做出，计划本季度内实施。
• Mgmt stance: 对EMR偏谨慎（宏观不确定性持续）；对大型交易爬坡中性偏正面（确认Phoenix如期，其他交易预计未来几个季度转化）。

Q2 — Vibhor Singhal

• Topic: 消费者垂直行业前景、医疗与科技垂直行业表现、Q4有机增长推断
• Key points:
  • 消费者垂直行业增长疲软，同比较差；原因是关税影响以及去年客户一个大型SAP项目暂停，尚未重启。
  • 医疗垂直行业持续表现良好，Q3受开放注册季节利好；科技垂直行业受益于大型科技客户及HARMAN收购贡献。
  • 对Q4有机增长（调整HARMAN后）的推断问题因电话断线未获完整回答。
• Mgmt stance: 对消费者垂直行业谨慎（前景混合，但部分早期赢单正在缓慢爬坡，已计入Q4预测）；对医疗和科技偏正面（已连续同比表现良好）。

Q3 — Ravi Menon

• Topic: 利润率表现与需求环境、HARMAN收购对胜率提升
• Key points:
  • 本季度利润率表现强劲，但Q4指引暗示可能出现小幅环比下滑（因部分 furlough 恢复被低工作日部分抵消）。
  • 需求环境无显著变化，客户仍在等待观望；1月许多客户敲定预算，管道依然以成本优化和供应商整合为主。
  • 客户计划将节省的资金重新投资于AI和先进转型项目；供应商分配因客户而异（同一家或多家）。
  • HARMAN DTS整合后，主要提升科技和通信领域胜率，其次为健康、消费者和EMR。
• Mgmt stance: 中性偏正面（对需求环境保持谨慎，但认为成本优化管道是机会，HARMAN将增强工程与AI产品创新能力）。

Q4 — Sandeep Shah

• Topic: 利润率指导、交易TCV放缓、资本回报
• Key points:
  • 利润率目标维持在17%–17.5% 区间，但受HARMAN收购稀释、大型交易不同利润率及可能的工资上调压力；管理层将逐季度权衡投资与利润率。
  • 本季度大型交易TCV有所放缓，但不反映决策周期变慢或竞争加剧；团队仍有大量交易在竞争周期中，预计势头将回升。
  • 手持现金61亿美元；回购仍是向股东返还现金的选项，将在适当时机考虑。
• Mgmt stance: 对利润率中性偏正面（坚持区间但承认多重压力）；对交易管道中性（前期有4个超大交易，TCV趋于集中）；对回购偏正面（继续作为可用选项）。

Q5 — Kumar Rakesh

• Topic: 增长战略、利润率权衡与并购
• Key points:
  • 无机战略与战略优先事项明确对齐，HARMAN DTS收购同时带来能力与新市场。
  • 有机与无机增长并行，持有现金使公司有能力扫描市场、寻找双赢投资机会。
  • 管理层未直接回应“是否应牺牲利润率换取与同行平齐的收入增长”。
• Mgmt stance: 偏正面（认为无机收购是实现增长的关键，将继续寻找战略投资机会）。

Q&A Batch (6-8 of 8)

Q6 — Rishi Jhunjhunwala

• Topic: Headcount increase, restructuring costs, and D&A spike
• Key points:
  • Headcount rise driven by DTS acquisition and ramp-up of a large Phoenix deal; attrition at 2% low for the quarter, trending same next quarter; campus hiring to resume next quarter.
  • Restructuring cost focused on obsolete skills in Europe (tough labor laws) and Capco, similar to Q1.
  • D&A spike due to accelerated amortization on an earlier acquisition; normalized level expected next quarter, but DTS/HARMAN will add higher amortization going forward.
• Mgmt stance: Neutral – headcount increase is deal-specific, not a broad hiring trend; restructuring is targeted; D&A normalization is temporary but offset by new acquisition amortization.

Q7 — Kawaljeet Saluja

• Topic: Excess cash and capital return (dividends vs. buyback)
• Key points:
  • Company has ~$6.5 billion excess cash; last year increased capital allocation and dividend payout (INR 6 per share last FY, ~INR 11 per share this FY, ~$1.3 billion).
  • Annualized YTD EPS payout ratio is ~88-89%; increased dividend prevents adding to excess cash while leaving room for acquisitions and organic investments.
  • Buyback is an option; board discussion needed; statutory considerations (e.g., no buyback within 12 months of a merger, no pending NCLT process) are currently conducive.
• Mgmt stance: Bullish – no current impediments to buyback; management will consider and update market; dividend already increased to manage cash.

Q8 — Kawaljeet Saluja (continued)

• Topic: Impact of delayed mega-deal ramp-ups on March quarter guidance
• Key points:
  • Cannot quantify guidance impact; delays are only in timing, not cancellation.
  • Phoenix deal (net new) ramped fully in Q3 as planned; other mega deals (vendor consolidation) have renewal element fully in, but new element delayed due to client situations or longer ramp-up (6 quarters).
  • Delays are expected to flow through in coming quarters.
• Mgmt stance: Neutral – delays are temporary and deal-specific; no change in overall expectations for renewal revenue; optimistic about future ramp-ups.